Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome

Human Molecular Genetics

Volumn 21, Issue 8, 2012, Pages 1824-1834

  Godavarthi, Swetha K ^a   Dey, Parthanarayan ^a   Maheshwari, Megha ^a   Jana, Nihar Ranjan ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; PARVALBUMIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN REGION; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; ENZYME DEFICIENCY; GENE EXPRESSION REGULATION; HAPPY PUPPET SYNDROME; HIPPOCAMPUS; INHIBITORY INTERNEURON; INTERNEURON; LOSS OF FUNCTION MUTATION; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMYGDALA; ANGELMAN SYNDROME; ANIMALS; ANXIETY; BRAIN; DISEASE MODELS, ANIMAL; GABAERGIC NEURONS; HIPPOCAMPUS; IMMEDIATE-EARLY PROTEINS; INTERNEURONS; MICE; PARVALBUMINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN-PROTEIN LIGASES;

MUS;

EID: 84859256771     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr614     Document Type: Article

References (54)

1. Clayton-Smith, J. and Laan, L. (2003) Angelman syndrome: a review of the clinical and genetic aspects. J. Med. Genet., 40, 87-95.
2. Williams, C.A. (2005) Neurological aspects of the Angelman syndrome. Brain Dev., 27, 88-94.
3. Jiang, Y., Lev-Lehman, E., Bressler, J., Tsai, T.F. and Beaudet, A.L. (1999) Genetics of Angelman syndrome. Am. J. Hum. Genet., 65, 1-6.
4. Fang, P., Lev-Lehman, E., Tsai, T.F., Matsuura, T., Benton, C.S., Sutcliffe, J.S., Christian, S.L., Kubota, T., Halley, D.J., Meijers-Heijboer, H. et al. (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet., 8, 129-135.
5. Kishino, T., Lalande, M. and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet., 15, 70-73.
6. Matsuura, T., Sutcliffe, J.S., Fang, P., Galjaard, R.J., Jiang, Y.H., Benton, C.S., Rommens, J.M. and Beaudet, A.L. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet., 15, 74-77.
7. Yamasaki, K., Joh, K., Ohta, T., Masuzaki, H., Ishimaru, T., Mukai, T., Niikawa, N., Ogawa, M., Wagstaff, J. and Kishino, T. (2003) Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet., 12, 837-847.
8. Albrecht, U., Sutcliffe, J.S., Cattanach, B.M., Beechey, C.V., Armstrong, D., Eichele, G. and Beaudet, A.L. (1997) Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet., 17, 75-78.
9. Glessner, J.T., Wang, K., Cai, G., Korvatska, O., Kim, C.E., Wood, S., Zhang, H., Estes, A., Brune, C.W., Bradfield, J.P. et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459, 569-573.
10. Huibregtse, J.M., Scheffner, M., Beaudenon, S. and Howley, P.M. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl Acad. Sci. USA, 92, 2563-2567.
11. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75, 495-505.
12. Scheffner, M., Nuber, U. and Huibregtse, J.M. (1995) Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature, 373, 81-83.
13. Nawaz, Z., Lonard, D.M., Smith, C.L., Lev-Lehman, E., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell Biol., 19, 1182-1189.
14. Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L., Eichele, G., Sweatt, J.D. andBeaudet, A.L. (1998)Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron, 21, 799-811.
15. Miura, K., Kishino, T., Li, E., Webber, H., Dikkes, P., Holmes, G.L. and Wagstaff, J. (2002) Neurobehavioral and electroencephalographic abnormalities inUbe3amaternal-deficientmice.Neurobiol.Dis., 9,149-159.
16. Dindot, S.V., Antalffy, B.A., Bhattacharjee, M.B. and Beaudet, A.L. (2008) The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet., 17, 111-118.
17. Weeber, E.J., Jiang, Y.H., Elgersma, Y., Varga, A.W., Carrasquillo, Y., Brown, S.E., Christian, J.M., Mirnikjoo, B., Silva, A., Beaudet, A.L. et al. (2003) Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci., 23, 2634-2644.
18. Sato, M. and Stryker, M.P. (2010) Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl Acad. Sci. USA, 107, 5611-5616.
19. Yashiro, K., Riday, T.T., Condon, K.H., Roberts, A.C., Bernardo, D.R., Prakash, R., Weinberg, R.J., Ehlers, M.D. and Philpot, B.D. (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci., 12, 777-783.
20. Greer, P.L., Hanayama, R., Bloodgood, B.L., Mardinly, A.R., Lipton, D.M., Flavell, S.W., Kim, T.K., Griffith, E.C., Waldon, Z., Maehr, R. et al. (2010) The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell, 140, 704-716.
21. Cooper, E.M., Hudson, A.W., Amos, J., Wagstaff, J. and Howley, P.M. (2004) Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J. Biol. Chem., 279, 41208-41217.
22. Smith, C.L., DeVera, D.G., Lamb, D.J., Nawaz, Z., Jiang, Y.H., Beaudet, A.L. and O'Malley, B.W. (2002) Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction.Mol. Cell Biol., 22, 525-535.
23. Khan, O.Y., Fu, G., Ismail, A., Srinivasan, S., Cao, X., Tu, Y., Lu, S. and Nawaz, Z. (2006) Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol. Endocrinol., 20, 544-559.
24. Conrad, C.D. (2008) Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev. Neurosci., 19, 395-411.
25. Herman, J.P. and Cullinan, W.E. (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci., 20, 78-84.
26. Herman, J.P., Figueiredo, H., Mueller, N.K., Ulrich-Lai, Y., Ostrander, M.M., Choi, D.C. and Cullinan, W.E. (2003) Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitaryadrenocortical responsiveness. Front. Neuroendocrinol., 24, 151-180.
27. Roozendaal, B., McEwen, B.S. and Chattarji, S. (2009) Stress, memory and the amygdala. Nat. Rev., 10, 423-433.
28. Conrad, C.D., McLaughlin, K.J., Harman, J.S., Foltz, C., Wieczorek, L., Lightner, E. and Wright, R.L. (2007) Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. J. Neurosci., 27, 8278-8285.
29. Ennaceur, A. and Delacour, J. (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res., 31, 47-59.
30. Belzung, C. and Le Pape, G. (1994) Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav., 56, 623-628.
31. Olmos-Serrano, J.L., Paluszkiewicz, S.M., Martin, B.S., Kaufmann, W.E., Corbin, J.G. and Huntsman, M.M. (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J. Neurosci., 30, 9929-9938.
32. Venero, C., Guadano-Ferraz, A., Herrero, A.I., Nordstrom, K., Manzano, J., de Escobar, G.M., Bernal, J. and Vennstrom, B. (2005) Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev., 19, 2152-2163.
33. Powell, E.M., Campbell, D.B., Stanwood, G.D., Davis, C., Noebels, J.L. and Levitt, P. (2003) Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci., 23, 622-631.
34. Czeh, B., Simon, M., van der Hart, M.G., Schmelting, B., Hesselink, M.B. and Fuchs, E. (2005) Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist. Neuropsychopharmacology, 30, 67-79.
35. Freund, T.F. (2003) Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci., 26, 489-495.
36. Alarid, E.T. (2006) Lives and times of nuclear receptors. Mol. Endocrinol., 20, 1972-1981.
37. Dennis, A.P., Haq, R.U. and Nawaz, Z. (2001) Importance of the regulation of nuclear receptor degradation. Front. Biosci., 6, D954-D959.
38. Herman, J.P., Cullinan, W.E., Ziegler, D.R. and Tasker, J.G. (2002) Role of the paraventricular nucleus microenvironment in stress integration. Eur. J. Neurosci., 16, 381-385.
39. Bornstein, S.R., Engeland, W.C., Ehrhart-Bornstein, M. and Herman, J.P. (2008) Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab., 19, 175-180.
40. Hu, W., Zhang, M., Czeh, B., Flugge, G. and Zhang, W. (2010) Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology, 35, 1693-1707.
41. McEwen, B.S. (1999) Stress and hippocampal plasticity. Ann. Rev. Neurosci., 22, 105-122.
42. McEwen, B.S. (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev., 87, 873-904.
43. McNaughton, N. (1997) Cognitive dysfunction resulting from hippocampal hyperactivity-a possible cause of anxiety disorder? Pharmacol. Biochem. Behav., 56, 603-611.
44. Vyas, A., Mitra, R., Shankaranarayana Rao, B.S. and Chattarji, S. (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci., 22, 6810-6818.
45. White, S.W., Oswald, D., Ollendick, T. and Scahill, L. (2009) Anxiety in children and adolescents with autism spectrum disorders. Clin. Psychol. Rev., 29, 216-229.
46. Allensworth, M., Saha, A., Reiter, L.T. and Heck, D.H. (2011) Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome. BMC Genet., 12, 7.
47. Jiang, Y.H., Pan, Y., Zhu, L., Landa, L., Yoo, J., Spencer, C., Lorenzo, I., Brilliant, M., Noebels, J. and Beaudet, A.L. (2010) Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS ONE, 5, e12278.
48. Pelc, K., Cheron, G. and Dan, B. (2008) Behavior and neuropsychiatric manifestations in Angelman syndrome. Neuropsychiat. Dis. Treat., 4, 577-584.
49. Smith, J.C. (2001) Angelman syndrome: evolution of the phenotype in adolescents and adults. Develop. Med. Child Neurol., 43, 476-480.
50. Amaral, D.G., Schumann, C.M. and Nordahl, C.W. (2008) Neuroanatomy of autism. Trends Neurosci., 31, 137-145.
51. Mishra, A. and Jana, N.R. (2008) Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome. Cell Mol. Life Sci., 65, 656-666.
52. Jana, N.R., Dikshit, P., Goswami, A. and Nukina, N. (2004) Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J. Biol. Chem., 279, 11680-11685.
53. Mishra, A., Dikshit, P., Purkayastha, S., Sharma, J., Nukina, N. and Jana, N.R. (2008) E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J. Biol. Chem., 283, 7648-7656.
54. Mulherkar, S.A. and Jana, N.R. (2010) Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol. Dis., 40, 586-592.